Spring Pharmaceutical GroupCYIG
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Spring Pharmaceutical Group (CYIG) in their 13F filings. The largest holder was Coston, McIsaac & Partners ($0).
- Company
- Spring Pharmaceutical Group
- CUSIP
- 84987P105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Coston, McIsaac & Partners | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is CYIG's weight in each manager's 13F, not the share of Spring Pharmaceutical Group the manager owns.